C. Maios

发表

Neuroleptics as therapeutic compounds stabilizing neuromuscular transmission in amyotrophic lateral sclerosis.

J. Julien, R. Robitaille, P. Drapeau, 2017, JCI insight.

Linkage mapping of the Mediterranean cypress, Cupressus sempervirens, based on molecular and morphological markers.

F. Aravanopoulos, N. Hamamouch, A. Doulis, 2011, Genetics and molecular research : GMR.

Pharmacological reduction of ER stress protects against TDP-43 neuronal toxicity in vivo

P. Drapeau, J. A. Parker, E. Kabashi, 2013, Neurobiology of Disease.

A single copy transgenic mutant FUS strain reproduces age-dependent ALS phenotypes in C. elegans

J. A. Parker, C. Maios, A. Labarre, 2021, microPublication biology.

Chemical and genetic rescue of in vivo progranulin-deficient lysosomal and autophagic defects

Babykumari P. Chitramuthu, J. A. Parker, A. Bateman, 2021, Proceedings of the National Academy of Sciences.

De Novo Truncating Mutation in Kinesin 17 Associated with Schizophrenia

L. DeLisi, J. Rapoport, E. Fombonne, 2010, Biological Psychiatry.

RNA-Based Therapy Utilizing Oculopharyngeal Muscular Dystrophy Transcript Knockdown and Replacement

N. Kharma, G. Rouleau, C. Néri, 2019, Molecular therapy. Nucleic acids.

Modulating the endoplasmic reticulum stress response attenuates neurodegeneration in a Caenorhabditis elegans model of spinal muscular atrophy

J. A. Parker, C. Maios, S. A. Patten, 2020, Disease Models & Mechanisms.

Genetic and pharmacological PARP inhibition reduces axonal degeneration in C. elegans models of ALS.

J. A. Parker, C. Maios, A. Labarre, 2022, Human molecular genetics.

Small Molecule Rescue of ATXN3 Toxicity in C. elegans via TFEB/HLH-30

J. A. Parker, C. Maios, Yasmin Fardghassemi, 2021, Neurotherapeutics.

The Novel Small Molecule TRVA242 Stabilizes Neuromuscular Junction Defects in Multiple Animal Models of Amyotrophic Lateral Sclerosis

R. Robitaille, P. Drapeau, J. A. Parker, 2019, Neurotherapeutics.

Methylene Blue Protects against TDP-43 and FUS Neuronal Toxicity in C. elegans and D. rerio

P. Drapeau, J. A. Parker, E. Kabashi, 2012, PloS one.

PIKFYVE inhibition mitigates disease in models of diverse forms of ALS

Daniela C. Zarnescu, D. Dickman, D. Zarnescu, 2023, Cell.

Mimicking of tau hyperphosphorylation in GABAergic motoneurons of C. elegans induces severe peripheral and neuronal alterations

N. Leclerc, J. A. Parker, J. Pilliod, 2023, bioRxiv.

Protein Assembly Modulation: A New Approach to ALS Therapeutics

G. S. Tomassy, D. Solas, V. Lingappa, 2023, bioRxiv.

Neuroleptics as therapeutic compounds stabilizing neuromuscular transmission in amyotrophic lateral sclerosis.

J. Julien, R. Robitaille, P. Drapeau, 2017, JCI insight.